Cancer Biomarker Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Rising Technological Advancements in the Development of Cancer Biomarkers
   3. Market Restraints
      1. High Development Costs and Complex Regulatory Pathways
      2. Limited Standardization and Reproducibility
   4. Market Opportunity
      1. Personalized Medicines
   5. Market Trends
      1. Growth in Liquid Biopsy Adoption
      2. Integration of Artificial Intelligence (AI) and Machine Learning
5. MARKET SEGMENTATION
   1. By Profiling Technology
      1. Omics
         1. Proteomics
         2. Genomics
         3. Other Omics Technologies
      2. Imaging
         1. Ultrasound Imaging
         2. Computed Tomography (CT)
         3. Magnetic Resonance Imaging (MRI)
         4. Positron Emission Tomography (PET)
         5. Mammography
   2. By Cancer
      1. Lung Cancer
      2. Breast Cancer
      3. Colorectal Cancer
      4. Prostate Cancer
      5. Melanoma
      6. Leukemia
      7. Thyroid Cancer
      8. Bladder Cancer
      9. Non-Hodgkin’s Lymphoma
      10. Kidney Cancer
      11. Other Cancer Types
   3. By Product
      1. Instruments
      2. Consumables
      3. Bioinformatics Software
   4. By Application
      1. Diagnostics
      2. R&D
      3. Prognostics
      4. Risk Assessment
      5. Other Applications
   5. By End-user
      1. Diagnostic Laboratories
      2. Biopharmaceutical Companies & CROs
      3. Research and Academic Institutes
      4. Other End Users
   6. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Abbott Laboratories
      2. Agilent Technologies
      3. Asuragen, Inc.
      4. bioMérieux SA
      5. BioGenex
      6. BioVision, Inc.
      7. Becton
      8. Bio-Rad Laboratories, Inc.
      9. CENTOGENE N.V.
      10. Dickinson and Company
      11. Exact Sciences
      12. F. Hoffmann-La Roche Ltd.
      13. Hologic, Inc.
      14. Invivoscribe, Inc.
      15. INOVIQ Ltd.
      16. Illumina, Inc.
      17. Quest Diagnostics
      18. QIAGEN
      19. Merck Millipore
      20. Meso Scale Diagnostics, LLC
      21. Myriad Genetics, Inc.
      22. Olink
      23. R&D Systems, Inc.
      24. Sysmex Corporation
      25. Siemens Healthineers
      26. Thermo Fisher Scientific Inc.
7. MARKET OPPORTUNITIES AND FUTURE TREND

Frequently Asked Questions

Q.1. What is the projected market value of the global cancer biomarkersmarket?

The global market of cancer biomarkersis projected to reach USD65.25Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global cancer biomarkersmarket?

The global cancer biomarkersmarket has an estimated annual growth rate of 11.5%.

Q.3. What are the recent trends of cancer biomarkersmarket?

Growth in liquid biopsy adoptionand integration of artificial intelligence (ai) and machine learning are someof the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in cancer biomarkers?

The major companies profiled in this report include Abbott Laboratories, Agilent Technologies, Asuragen, Inc., bioMérieux SA, BioGenex, BioVision, Inc., Becton, Bio-Rad Laboratories, Inc., CENTOGENE N.V., Dickinson and Company, Exact Sciences, F. Hoffmann-La Roche Ltd., Hologic, Inc., Invivoscribe, Inc., INOVIQ Ltd., Illumina, Inc., Quest Diagnostics, QIAGEN, Merck Millipore, Meso Scale Diagnostics, LLC, Myriad Genetics, Inc., Olink, R&D Systems, Inc., Sysmex Corporation, Siemens Healthineers, Thermo Fisher Scientific Inc., among others.  

Q.5. Which is the largest regional market in the cancer biomarkers?

North America is the largest regional market for cancer biomarkers.